Skip to main content
Log in

Analysis of enterohepatic circulation of cefixime in rat by fast inverse Laplace transform (FILT)

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

The enterohepatic circulation of cefixime in rat was evaluated by a nonlinear least square analysis program, MULTI(FILT), into which the fast inverse Laplace transform (FILT) was incorporated. The plasma time course in the bile duct-cannulated rat exhibited a biexponential curve after the rapid iv administration of cefixime. Several pharmacokinetic models for the enterohepatic circulation were constructed based on the recirculatory concept and the Laplace-transformed equations corresponding to these models were derived by means of the method of transfer function. The transformed equations were simultaneously fitted to the time courses of plasma concentration in rats with laparotomy and with bile duct cannula. The optimum model was selected based on the Akaike's information criterion (AIC). The local moment characteristics for a single pass through enterohepatic circulation were further calculated from the time courses of both the plasma concentration and the amount excreted into the bile. The recovery ratio (Fc and the mean circulatory time (¯tc through a single pass of enterohepatic circulation were estimated 27.9% and 1.07 hr, respectively. The recovery ratio (Fa and the mean absorption time (¯ta for the absorption process from the intestinal tract into the systemic circulation were 68.3% and 0.0234 hr, respectively. The recovery ratio (Fb and the mean transit time (¯tb)for the disposition process through the systemic circulation into the bile were 40.8% and 1.05hr, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

A i :

coefficient

a i :

exponent

\(\tilde C_p^{iv} \)(s):

Laplace transform of the time course of plasma following intravenous dose

\(\tilde C_p^{po} \)(s):

Laplace transform of the time course of plasma following oral administration dose

\(\tilde C_p^1 \)(s):

Laplace transform of the time course of plasma concentration without EHC

CLb :

clearance into the bile

CL1 :

total clearance through the single EHC (=CLb/Fb)

Div :

intravenous dose

Dpo :

oral administration dose

Fa :

recovery (availability) from intestinal tract to systemic circulation

Fb :

recovery from systemic circulation to intestinal tract

F′a :

recovery from oral dose (absolute availability)

Fc :

recovery through a single pass of EHC

Fg :

recovery through the stomach

\(\tilde f_a \)(s):

transfer function corresponding to the process outside the body through the intestinal tract

\(\tilde f_a^\prime \)(s):

transfer function for oral dose

\(\tilde f_b \)(s):

transfer function through the systemic circulation into the bile

\(\tilde f_c \)(s):

transfer function for a single pass of EHC

\(\tilde f_g \)(s):

transfer function through the stomach

fi(t):

weight function for the processi

\(\tilde f_i \)(s):

Laplace transform off t (t)

\(\tilde f_r \)(s):

transfer function corresponding to the recirculatory process

ka :

absorption rate constant

s :

Laplace variable

\(\bar t_a \) :

mean transit time for the absorption process from the intestinal tract

\(\bar t_a^\prime \) a :

mean transit time for oral dose (=MAT)

\(\bar t_b \) :

mean transit time for the disposition process in the body

\(\bar t_c \) :

mean transit time for a single pass of EHC

t 0 :

gap time

References

  1. P. V. Pedersen and R. Miller. Pharmacokinetics and bioavailability of cimetidene in humans.J. Pharm. Sci. 69:394–398 (1980).

    Article  CAS  PubMed  Google Scholar 

  2. P. V. Pedersen and R. Miller. Pharmacokinetics of doxycline reabsorption.J. Pharm. Sci. 69:204–207 (1980).

    Article  CAS  PubMed  Google Scholar 

  3. F. L. S. Tse, F. Ballard, J. M. Jaffe, and H. J. Schwarz, Enterohepatic circulation of radioactivity following an oral dose of [14C]temazeparn in the rat.J. Pharm. Pharmacol. 35:225–228 (1983).

    Article  CAS  PubMed  Google Scholar 

  4. B. E. Dahlstrom and L. K. Paalzow. Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat.J. Pharmacokin. Biopharm. 6:505–519 (1978).

    Article  CAS  Google Scholar 

  5. K. Singh, J. M. Orr, and F. S. Abbott. Pharmacokinetics and enterohepatic circulation of 2-n-propyl-4-pentenoic acid in the rat.Drug Metab. Dispos. 16:848–852 (1988).

    CAS  PubMed  Google Scholar 

  6. N. Watari, M. Hanawa, M. Iwai, and N. Kaneniwa.J. Pharmacobiodyn. 7:811–819 (1984).

    Article  CAS  PubMed  Google Scholar 

  7. T. Tsuchida, M. Terakawa, K. Ishibashi, H. Noguchi, and R. Kato.Arzneim. Forsch. 30:1650–1653 (1980).

    Google Scholar 

  8. T. A. Shepard, R. H. Reuning, and L. J. Aarons. Interpretation of area under the curve measurements for drugs subject to enterohepatic cycling.J. Pharm. Sci. 74:227–228 (1985).

    Article  CAS  PubMed  Google Scholar 

  9. K. S. Pang and J. R. Gillette. A theoretical examination of the effects of gut wall metabolism, hepatic elimination, and enterohepatic recycling on estimates of bioavailability and of hepatic blood flow.J. Pharmacokin. Biopharm. 6:355–367 (1978).

    Article  CAS  Google Scholar 

  10. F. L. S. Tse, F. Ballard, and J. Skinn. Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulation.J. Pharmacokin. Biopharm. 10:455–460 (1982).

    Article  CAS  Google Scholar 

  11. T. A. Shepard, G. F. Lockwood, L. J. Aarons, and I. D. Abrahams. Mean residence time for drugs subject to enterohepatic cycling.J. Pharmacokin. Biopharm. 17:327–345 (1989).

    Article  CAS  Google Scholar 

  12. A. F. Hofmann, C. Cravetto, G. Molino, G. Belforte, and B. Bona. Simulation of the metabolism and enterohepatic circulation of endogenous deoxycholic acid in humans using a physiologic pharmacokinetic model for bile acid metabolism.Gastroenterology 93:693–709 (1987).

    CAS  PubMed  Google Scholar 

  13. T. A. Shepard, D. J. Gannaway, and G. F. Lockwood. Accumulation and time to steady state for drugs subject to enterohepatic cycling: A simulation study.J. Pharm. Sci. 74:1331–1333 (1985).

    Article  CAS  PubMed  Google Scholar 

  14. W. A. Colburn. Pharmacokinetic analysis of concentration-time data obtained following administration of drugs that are recycled in the bile.J. Pharm. Sci. 73:313–317 (1984).

    Article  CAS  PubMed  Google Scholar 

  15. Y. Yano, K. Yamaoka, and H. Tanaka. A nonlinear least squares program, MULTI(FILT), based on fast inverse Laplace transform for microcomputers.Chem. Pharm. Bull 37:1035–1038 (1989).

    Article  CAS  PubMed  Google Scholar 

  16. T. Hosono. Numerical inversion of Laplace transform and some applications to wave optics.Radio Sci. 16:1015–1019 (1981).

    Article  Google Scholar 

  17. H. Yamanaka, Y. Chiba, K. Kawabata, H. Takasugi, T. Masugi, and T. Takaya. Study ofβ-lactam antibiotics synthesis and biological activity of a new orally active cephalosporin, cefixime (FK027).J. Antibiot. 38:1738–1751 (1985).

    Article  CAS  PubMed  Google Scholar 

  18. Y. Tokuma, M. Sekiguti, T. Fujiwara, and H. Noguchi. Absorption, distribution, excretion and metabolism of cefixime in rats.Xenobio. Metab. Dispos. 2:673–648 (1987).

    Google Scholar 

  19. H. Sakamoto, S. Hirose, Y. Mine, S. Gosima, M. Nisida, and S. Kuwahara. Pharmacokinetics of cefixime, a new oral cephalosporin, in experimental animals.Chemotherapy (Japan)33:(S6): 157–167 (1985).

    CAS  Google Scholar 

  20. M. Weiss. Moments of physiological transit time distributions and the time course of drug disposition in the body.J. Math. Biol. 15:305–318 (1982).

    Article  CAS  PubMed  Google Scholar 

  21. K. Yamaoka, T. Nakagawa, and T. Uno. Statistical moment in pharmacokinetics.J. Pharmacokin. Biopharm. 6:547–558 (1978).

    Article  CAS  Google Scholar 

  22. T. Kakutani, K. Yamaoka, M. Hashida, and H. Sezaki. A new method for assessment of drug disposition in muscle: application of statistical moment theory to local perfusion systems.J. Pharmacokin. Biopharm. 13:609–631 (1985).

    Article  CAS  Google Scholar 

  23. Y. Yano, K. Yamaoka, Y. Aoyama, and H. Tanaka. Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT).J. Pharmacokin. Biopharm. 17:179–202 (1989).

    Article  CAS  Google Scholar 

  24. K. Yamaoka, T. Nakagawa, and T. Uno. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetics equations.J. Pharmacokin. Biopharm. 6:165–175 (1978).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamaoka, K., Kanba, M., Toyoda, Y. et al. Analysis of enterohepatic circulation of cefixime in rat by fast inverse Laplace transform (FILT). Journal of Pharmacokinetics and Biopharmaceutics 18, 545–559 (1990). https://doi.org/10.1007/BF01073938

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01073938

Key words

Navigation